Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update (30-month) of the pivotal ERIVANCE BCC study.
Aleksandar Sekulic
Consultant or Advisory Role - Roche/Genentech (U)
Michael Robert Migden
Consultant or Advisory Role - Roche/Genentech
Honoraria - Genentech; Lilly; Novartis
Research Funding - Genentech
Expert Testimony - Novartis (U)
Other Remuneration - Roche/Genentech
Nicole Basset-Seguin
Consultant or Advisory Role - Roche
Honoraria - Roche
Claus Garbe
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Anja Gesierich
Honoraria - Roche
Other Remuneration - Roche
Christopher Lao
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Chris Miller
No relevant relationships to disclose
Laurent Mortier
Consultant or Advisory Role - Roche
Honoraria - Roche
Dedee F. Murrell
Consultant or Advisory Role - Roche
Research Funding - Roche
Omid Hamid
Consultant or Advisory Role - Genentech (U)
Honoraria - Genentech
Research Funding - Genentech
Fernando Quevedo
No relevant relationships to disclose
Jeannie Hou
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Mukta Tripathi
Consultant or Advisory Role - Genentech
Dirk Schadendorf
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Roche
Research Funding - Merck